Related references
Note: Only part of the references are listed.BAFF and APRIL expression as an autoimmune signature of membranous nephropathy
Seung Seok Han et al.
ONCOTARGET (2018)
Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP)
Julian Kamhieh-Milz et al.
CLINICAL IMMUNOLOGY (2018)
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors
Michele Vigolo et al.
NATURE COMMUNICATIONS (2018)
Synovial IL-9 facilitates neutrophil survival, function and differentiation of Th17 cells in rheumatoid arthritis
Kaustav Chowdhury et al.
ARTHRITIS RESEARCH & THERAPY (2018)
IL-15 and RANKL Play a Synergistically Important Role in Osteoclastogenesis
Iichiro Okabe et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
S. Hipp et al.
LEUKEMIA (2017)
Chicoric acid suppresses BAFF expression in B lymphocytes by inhibiting NF-κB activity
Lingxi Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
G alpha q Regulates the Development of Rheumatoid Arthritis by Modulating Th1 Differentiation
Dashan Wang et al.
MEDIATORS OF INFLAMMATION (2017)
Selective Binding BAFF/APRIL by the In and Outside Conservative Region of BCMA
Chang Zheng et al.
PROTEIN AND PEPTIDE LETTERS (2017)
BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells
Cristian R. Smulski et al.
CELL REPORTS (2017)
Synovial CD4+T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis
G. Reynolds et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
J. T. Merrill et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues
Gareth W. Jones et al.
IMMUNOLOGY (2016)
Inhibition of B-cell apoptosis is mediated through increased expression of Bcl-2 in patients with rheumatoid arthritis
Jin Yang et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity
Jiaxi Chen et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity
Dashan Wang et al.
PLOS ONE (2016)
Elevated Ratio of Th17 Cell-Derived Th1 Cells (CD161(+)Th1 Cells) to CD161(+)Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis Patients
Shigeru Kotake et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis
Nida Meednu et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis
Samuel Garcia et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Generation mechanism of RANKL+ effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis
Yuri Ota et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Targeting B-cell maturation antigen in multiple myeloma
Yu-Tzu Tai et al.
IMMUNOTHERAPY (2015)
Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis
Yan Chang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus
Shingo Nakayamada et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2015)
Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis
Abby Jones Weldon et al.
JOURNAL OF RHEUMATOLOGY (2015)
APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis
Yan Chang et al.
MOLECULAR IMMUNOLOGY (2015)
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis
Francesco Ciccia et al.
RHEUMATOLOGY (2015)
Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis
Juan D. Canete et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjogren's syndrome: results of the BELISS study
Raphaele Seror et al.
ARTHRITIS RESEARCH & THERAPY (2015)
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Sarah A. Laurent et al.
NATURE COMMUNICATIONS (2015)
Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Pilot Trial
R. F. van Vollenhoven et al.
ARTHRITIS & RHEUMATOLOGY (2015)
BAFF Regulates Follicular Helper T Cells and Affects Their Accumulation and Interferon-γ Production in Autoimmunity
Christine M. Coquery et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study
Xavier Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
David Isenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The efficacy of novel B cell biologics as the future of SLE treatment: A review
Ameer Kamal et al.
AUTOIMMUNITY REVIEWS (2014)
TLR9 and BAFF: Their expression in patients with IgA nephropathy
Weiwei Li et al.
MOLECULAR MEDICINE REPORTS (2014)
The role of a proliferation-inducing ligand (APRIL) in the pathogenesis of rheumatoid arthritis
J. Zhao et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate
Mark C. Genovese et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo-Controlled Trial
M. C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2013)
Belimumab - an anti-BLyS human monoclonal antibody for rheumatoid arthritis
Xingzhong Jin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
The TACI Receptor Regulates T-Cell-Independent Marginal Zone B Cell Responses through Innate Activation-Induced Cell Death
William A. Figgett et al.
IMMUNITY (2013)
The BAFF Receptor Transduces Survival Signals by Co-opting the B Cell Receptor Signaling Pathway
Edina Schweighoffer et al.
IMMUNITY (2013)
B-cell biology and development
Kathrin Pieper et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
Gang Xin et al.
JOURNAL OF NEPHROLOGY (2013)
BAFF and TACI Gene Expression Are Increased in Patients with Untreated Very Early Rheumatoid Arthritis
Rita A. Moura et al.
JOURNAL OF RHEUMATOLOGY (2013)
Association between-871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients
Adeline Ruyssen-Witrand et al.
RHEUMATOLOGY (2013)
BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
Fabien B. Vincent et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Comparative study on the level of B lymphocyte stimulator (BlyS) and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis patients
Yan Geng et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2012)
The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland
Jelle L. Vosters et al.
RHEUMATOLOGY (2012)
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
Ellen M. Ginzler et al.
ARTHRITIS RESEARCH & THERAPY (2012)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival
Rogier M. Reijmers et al.
BLOOD (2011)
A single NF kappa B system for both canonical and non-canonical signaling
Vincent Feng-Sheng Shih et al.
CELL RESEARCH (2011)
Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses
Claudia Bossen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells
Yun-Ju Woo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival
Rita A. Moura et al.
RHEUMATOLOGY (2011)
Expanding TRAF function: TRAF3 as a tri-faced immune regulator
Hans Haecker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy
Inmaculada de la Torre et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion
Mitchell Thorn et al.
CELLULAR IMMUNOLOGY (2010)
Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices
M. Hegazy et al.
CLINICAL IMMUNOLOGY (2010)
Targeting B cells with biologics in systemic lupus erythematosus
Antonio La Cava
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Allosteric Regulation of the Ubiquitin: NIK and Ubiquitin: TRAF3 E3 Ligases by the Lymphotoxin-β Receptor
Hideki Sanjo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
BAFF Receptor Signaling Aids the Differentiation of Immature B Cells into Transitional B Cells following Tonic BCR Signaling
Sarah L. Rowland et al.
JOURNAL OF IMMUNOLOGY (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Transmembrane BAFF From Rheumatoid Synoviocytes Requires Interleukin-6 to Induce the Expression of Recombination-Activating Gene in B Lymphocytes
Caroline Rochas et al.
ARTHRITIS AND RHEUMATISM (2009)
Mitochondrial cell death effectors
Dirk Brenner et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking
Fiona C. Kimberley et al.
FASEB JOURNAL (2009)
Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor
Lei Zhang et al.
JOURNAL OF NEUROSCIENCE (2009)
B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans
Klaus Warnatz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Multiple signaling pathways promote B lymphocyte stimulator-dependent B-cell growth and survival
Robert T. Woodland et al.
BLOOD (2008)
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
Elodie Belnoue et al.
BLOOD (2008)
Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation
Almut Meyer-Bahlburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
Sivakumar Vallabhapurapu et al.
NATURE IMMUNOLOGY (2008)
Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling
Jason E. Stadanlick et al.
NATURE IMMUNOLOGY (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis
Queenie Lai Kwan Lam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex
Atsushi Matsuzawa et al.
SCIENCE (2008)
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen et al.
BLOOD (2008)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Reva C. Lawrence et al.
ARTHRITIS AND RHEUMATISM (2008)
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus
Maria Dall'Era et al.
ARTHRITIS AND RHEUMATISM (2007)
Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL
Katsuya Nagatani et al.
ARTHRITIS AND RHEUMATISM (2007)
In vitro and in vivo activation induces BAFF and APRIL expression in B cells
Van Trung Chu et al.
JOURNAL OF IMMUNOLOGY (2007)
TACI is required for efficient plasma cell differentiation in response to T-Independent type 2 antigens
George T. Mantchev et al.
JOURNAL OF IMMUNOLOGY (2007)
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
Joanna R. Groom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism
Alina Patke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
BLyS and APRIL in rheumatoid arthritis
TM Seyler et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
ΔBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models
AL Gavin et al.
JOURNAL OF IMMUNOLOGY (2005)
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
ES Day et al.
BIOCHEMISTRY (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
APRIL-deficient mice have normal immune system development
E Varfolomeev et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF
A Tardivel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function
L Gorelik et al.
JOURNAL OF IMMUNOLOGY (2004)
B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation
S Shulga-Morskaya et al.
JOURNAL OF IMMUNOLOGY (2004)
Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: Implications for intracellular signaling regulation
CZ Ni et al.
JOURNAL OF IMMUNOLOGY (2004)
B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers
ZSM Rahman et al.
JOURNAL OF IMMUNOLOGY (2004)
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
JT Opferman et al.
NATURE (2003)
ΔBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF
AL Gavin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells
L Gorelik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF
A Craxton et al.
BLOOD (2003)
Evolving concepts of rheumatoid arthritis
GS Firestein
NATURE (2003)
Ligand-receptor binding revealed by the TNF family member TALL-1
YF Liu et al.
NATURE (2003)
Expression and regulation of toll-like receptor 2 in rheumatoid arthritis synovium
R Seibl et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
G-CSF-stimulated neutrophils are a prominent source of functional BLyS
P Scapini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor
D Seshasayee et al.
IMMUNITY (2003)
TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-κB activation and IL-10 production
LG Xu et al.
JOURNAL OF IMMUNOLOGY (2002)
An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein
B Pradet-Balade et al.
EMBO JOURNAL (2002)
Analysis on the association of human BLYS (BAFF TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis
A Kawasaki et al.
GENES AND IMMUNITY (2002)
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases
V Roschke et al.
JOURNAL OF IMMUNOLOGY (2002)
BAFF: A fundamental survival factor for B cells
F Mackay et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators
BL Hsu et al.
JOURNAL OF IMMUNOLOGY (2002)
CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis
YM Kang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase
M López-Fraga et al.
EMBO REPORTS (2001)
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
B Schiemann et al.
SCIENCE (2001)
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF
JS Thompson et al.
SCIENCE (2001)
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS
JA Gross et al.
IMMUNITY (2001)
Activation and accumulation of B cells in TACI-deficient mice
MH Yan et al.
NATURE IMMUNOLOGY (2001)
Regulation of the T-independent humoral response by TACI
GU von Bülow et al.
IMMUNITY (2001)
APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis
W Roth et al.
CELL DEATH AND DIFFERENTIATION (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
PF Dijkers et al.
CURRENT BIOLOGY (2000)
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
SA Marsters et al.
CURRENT BIOLOGY (2000)
Share Paper
